BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2020.
World J Clin Oncol. Dec 24, 2020; 11(12): 1018-1028
Published online Dec 24, 2020. doi: 10.5306/wjco.v11.i12.1018
Table 2 Comparative characteristics of triple negative breast cancer and hormone positive breast cancer patients
Variables
Levels
Triple negative breast cancer, n (%)
Hormone positive breast cancer, n (%)
Agemean ± SD47.24 ± 11.549.27 ± 12.0
HistologyDuctal46 (50.5)45 (49.5)
Others3 (33.3)6 (66.7)
Total49 (49.0)51 (51.0)
GradeII9 (25.7)26 (74.3)
III37 (66.1)19 (33.9)
UNK3 (33.3)6 (66.7)
Total49 (49.0)51 (51.0)
Tumor sizeT14 (57.1)3 (42.9)
T2/T326 (45.6)31 (54.4)
UNK19 (52.8)17 (47.2)
Total49 (49.0)51 (51.0)
NodesNegative23 (62.1)14 (37.8)
Positive21 (42.0)29 (58.0)
UNK5 (38.4)8 (61.6)
Total49 (49.0)51 (51.0)
MetastasisNegative23 (60.5)15 (39.5)
Positive21 (42.8)28 (57.2)
UNK5 (38.4)8 (61.6)
Total49 (49.0)51 (51.0)


Write to the Help Desk